Silo Pharma, Inc.

SILO

Silo Pharma, Inc.

SILO

Insider Sentiment (TTM):

Last Purchase:2025-12-15Last Sale:-Shares Purchased (TTM):10,500Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,055,805Shares Outstanding:13,709,211Institutional Ownership Pct.:7.70%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	3	4	5	4	4	3	4	5	5	3	4	0
Short Term Investments	2	2	2	2	2	2	3	3	3	4	4	9
Crypto Asset Fair Value Current	0	0	0	0	-	-	-	-	-	-	-	-
Other Assets Current	-	0	0	-	-	-	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	0	1	0	0	0	0	0	0	0	0	0	0
Assets Current	6	7	7	6	6	6	7	8	8	7	8	9
Prepaid Expense Noncurrent	-	-	-	-	-	-	-	-	-	0	0	0
Prepaid Expense And Other Assets Noncurrent	-	-	-	-	0	0	0	0	0	-	0	-
Assets Noncurrent
Receivables Net Current	-	-	-	-	-	-	-	-	-	-	-	0
Intangible Assets Net Excluding Goodwill	0	0	0	0	0	0	0	0	0	-	-	-
Assets Noncurrent	0	0	0	0	0	0	0	0	0	-	0	-
Assets	6	7	8	6	7	6	7	9	8	7	8	9
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	0	1	1	1	1	1	2	1	1	1	1	1
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	0	0	0
Contract With Customer Liability Current	-	0	0	0	0	0	0	0	0	-	0	-
Liabilities Current	1	1	1	1	1	1	2	1	1	1	1	1
Deferred Revenue Noncurrent	-	-	-	-	-	-	-	-	-	1	1	1
Liabilities Noncurrent
Contract With Customer Liability Noncurrent	-	1	1	1	1	1	1	1	1	-	1	-
Liabilities Noncurrent	-	1	1	1	1	1	1	1	1	1	1	1
Liabilities	1	1	1	1	2	2	2	2	2	2	2	1
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	27	27	26	24	22	20	20	20	19	18	18	17
Additional Paid In Capital Preferred Stock	-	-	-	-	-	-	-	-	-	-	18	-
Treasury Stock Value	-	-	-	-	-	-	-	-0	-1	-1	-0	-0
Treasury Stock Preferred Value	-	-	-	-	-	-	-	-	-	-	-0	-
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	0	0	0	-0	-0
Retained Earnings Accumulated Deficit	-22	-21	-19	-19	-18	-16	-15	-14	-13	-12	-11	-10
Stockholders Equity	5	6	6	5	5	4	5	7	6	5	6	7
Liabilities And Stockholders Equity	6	7	8	6	7	6	7	9	8	7	8	9
Series C Preferred Stock	-	-	-	-	-	-	-	-	-	-	-	0
Interest Receivable Noncurrent	-	-	-	-	-	-	-	-	-	-	-	0
Interest Receivable Current	-	-	-	-	-	-	-	-	-	-	0	-
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	7	100	100	100	100	100	100	100	100	100	100	500
Treasury Stock Common Shares	-	-	-	-	-	-	0	0	0	0	0	0
Common Stock Shares Issued	1	1	1	1	1	0	0	0	0	0	0	0
Shares Outstanding	1	1	1	1	1	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-0.17%	4.57%	-28.09%	-	-	-	-	-	-	-	-	-
2025	-45.52%	-21.35%	-18.28%	-12.84%	-0.57%	-22.68%	0.92%	-22.76%	-20.69%	51.47%	17.65%	30.00%
2024	-34.46%	-45.59%	-1.69%	-4.16%	-15.20%	-16.00%	-24.88%	-19.67%	30.89%	-14.00%	-61.36%	-53.04%
2023	-	-	-	-	-	-	10.78%	8.55%	12.27%	2.38%	4.15%	-43.01%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	5.36	9.65	11.36	8.70	6.07	4.73	4.29	7.91	5.84	7.87	9.90	13.14
Quick Ratio	5.10	8.90	11.04	8.38	5.96	4.55	4.28	7.67	5.75	7.72	9.88	13.02
Working Capital	4.65M	6.10M	6.74M	5.46M	5.32M	4.42M	5.46M	7.22M	6.41M	6.00M	6.91M	8.24M
Leverage & Debt
Debt to Equity	0.22	0.24	0.21	0.27	0.35	0.47	0.47	0.26	0.35	0.31	0.25	0.20
Interest Coverage TTM	-112.03	-123.84	-114.76	-1,088.94	-1,019.15	-931.88	-925.59	-797.97	-751.85	-773.33	-791.87	-946.22
Debt Ratio	0.18	0.19	0.17	0.22	0.26	0.32	0.32	0.21	0.26	0.24	0.20	0.17
Efficiency & Turnover
Asset Turnover TTM	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Days Sales Outstanding TTM	-	-	-	-	-	-	-	-	-	-	-	281.87
Receivables Turnover TTM	-	-	-	-	-	-	-	-	-	-	-	1.29
Per Share Metrics
Diluted EPS TTM	-4.07	-5.30	-7.56	-8.16	-11.69	-15.45	-17.89	-13.19	-17.26	-18.80	-18.01	-20.46
Free Cash Flow Per Share TTM	-3.04	-4.20	-8.34	-7.71	-12.40	-15.50	-15.62	-13.34	-17.44	-17.62	-15.70	-15.43
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	11.90%	38.57%	65.24%	91.90%	91.90%	91.90%	91.90%	91.90%	91.90%	91.90%	73.52%
Operating Profit Margin TTM	-8,250.46%	-6,631.16%	-5,936.95%	-7,361.09%	-7,164.96%	-6,824.09%	-6,526.44%	-5,625.46%	-5,297.23%	-5,452.86%	-5,347.41%	-4,825.17%
Net Profit Margin TTM	-8,269.53%	-6,717.40%	-5,863.50%	-7,041.12%	-6,789.22%	-6,411.26%	-6,092.59%	-5,247.34%	-4,874.74%	-4,987.32%	-5,132.57%	-4,707.01%
Growth Metrics
Net Revenue Growth (1Y)	-25.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-20.00%	-20.00%	-20.00%	-0.57%	147.16%
Net Income Growth (1Y)	-8.65%	4.77%	-3.76%	34.18%	39.27%	28.55%	18.70%	-10.82%	-23.01%	-14.60%	-5.32%	27.23%
EPS Growth (1Y)	-65.18%	-65.73%	-57.74%	-38.14%	-32.26%	-17.82%	-0.66%	-35.55%	-20.46%	-5.91%	-29.78%	-18.12%
Valuation Metrics
P/E TTM	-1.53	-1.02	-0.67	-1.27	-0.81	-1.14	-0.75	-1.25	-0.87	-1.56	-1.20	-1.22
P/B TTM	1.40	0.87	0.45	1.29	0.80	1.31	0.65	0.70	0.51	1.06	0.72	0.69
P/S TTM	126.15	68.48	39.55	89.34	54.87	72.81	45.45	65.66	42.36	77.58	61.54	57.63
Market Cap	6.82M	4.94M	2.85M	6.44M	3.96M	5.25M	3.28M	4.73M	3.05M	5.59M	4.44M	5.19M
Enterprise Value	3.54M	1.04M	-1.90M	2.52M	-377.44K	2.11M	-628.62K	-126.49K	-1.45M	2.93M	912.93K	4.99M
Calculated Values
Free Cash Flow TTM	-3.34M	-3.84M	-4.66M	-4.80M	-5.19M	-4.64M	-3.83M	-3.83M	-3.55M	-3.37M	-3.22M	-3.20M
Net Debt	-3.28M	-3.90M	-4.75M	-3.92M	-4.33M	-3.14M	-3.91M	-4.86M	-4.51M	-2.67M	-3.52M	-199.84K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-15Purchase

Owner: Weisblum, Eric

Title: Chief Executive Officer

Shares: 5,000

Price/Share: $0.42

Value: $2,100.00

Shares Owned: 216,932

Relationship: Director,Officer

Ownership: Direct

2025-11-21Purchase

Owner: Weisblum, Eric

Title: Chief Executive Officer

Shares: 1,000

Price/Share: $0.37

Value: $370.00

Shares Owned: 211,932

Relationship: Director,Officer

Ownership: Direct

2025-11-19Purchase

Owner: Weisblum, Eric

Title: Chief Executive Officer

Shares: 4,500

Price/Share: $0.41

Value: $1,845.00

Shares Owned: 209,932

Relationship: Director,Officer

Ownership: Direct

2025-05-27Purchase

Owner: Weisblum, Eric

Title: Chief Executive Officer

Shares: 10,000

Price/Share: $0.43

Value: $4,300.00

Shares Owned: 197,932

Relationship: Director,Officer

Ownership: Direct

2024-12-13Purchase

Owner: Weisblum, Eric

Title: CEO and President

Shares: 2,500

Price/Share: $0.84

Value: $2,100.00

Shares Owned: 187,932

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-15	Weisblum, Eric	Director,Officer	Chief Executive Officer	Direct	Purchase	5,000	0.42	$2,100.00	216,932	4
2025-11-21	Weisblum, Eric	Director,Officer	Chief Executive Officer	Direct	Purchase	1,000	0.37	$370.00	211,932	4
2025-11-19	Weisblum, Eric	Director,Officer	Chief Executive Officer	Direct	Purchase	4,500	0.41	$1,845.00	209,932	4
2025-05-27	Weisblum, Eric	Director,Officer	Chief Executive Officer	Direct	Purchase	10,000	0.43	$4,300.00	197,932	4
2024-12-13	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	2,500	0.84	$2,100.00	187,932	4
2024-11-22	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	2,500	0.90	$2,250.00	185,432	4
2024-06-12	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	4,438	1.11	$4,926.18	180,432	4
2024-04-05	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	400	2.03	$812.00	175,432	4
2024-04-01	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	1,100	1.91	$2,101.00	174,432	4
2023-12-20	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	200	1.61	$322.00	169,924	4
2023-12-15	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	900	1.52	$1,368.00	169,224	4
2023-12-07	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	324	1.36	$440.64	168,124	4
2023-11-30	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	1,000	1.53	$1,530.00	167,124	4
2023-11-27	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	250	1.78	$445.00	165,124	4
2023-11-21	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	300	1.56	$468.00	164,474	4
2023-11-17	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	1,800	1.54	$2,772.00	160,124	4
2023-05-26	Ryweck, Daniel E.	Officer	Chief Financial Officer	Direct	Purchase	1,000	2.13	$2,130.00	5,000	4
2023-05-18	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	500	2.11	$1,055.00	157,724	4
2022-12-20	Weisblum, Eric	Director,Officer	CEO and President	Direct	Purchase	130	2.72	$353.60	154,854	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

7.70%

Inst. Shares: 1,055,805

Shares Outstanding: 13,709,211

2025-12-31

14.26%

Inst. Shares: 1,195,221

Shares Outstanding: 8,382,272

2025-09-30

15.47%

Inst. Shares: 1,443,343

Shares Outstanding: 9,331,346

2025-06-30

6.48%

Inst. Shares: 406,814

Shares Outstanding: 6,279,733

2025-03-31

5.53%

Inst. Shares: 247,864

Shares Outstanding: 4,484,456

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,055,805	13,709,211	7.70%
2025-12-31	1,195,221	8,382,272	14.26%
2025-09-30	1,443,343	9,331,346	15.47%
2025-06-30	406,814	6,279,733	6.48%
2025-03-31	247,864	4,484,456	5.53%
2024-12-31	160,694	3,680,389	4.37%
2024-09-30	311,192	4,301,847	7.23%
2024-06-30	75,767	3,052,666	2.48%
2024-03-31	112,818	2,866,934	3.94%
2023-12-31	160,652	3,079,874	5.22%
2023-09-30	105,573	3,108,797	3.40%
2023-06-30	99,698	3,153,852	3.16%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Silo Pharma, Inc. (SILO) — SEC Financial Statements & Analysis

Silo Pharma, Inc. (SILO) is a pharmaceutical preparations company, incorporated in NV. Silo Pharma, Inc. trades on Nasdaq as: SILO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Silo Pharma, Inc. reported a -25.00% year-over-year revenue growth, a Gross Profit Margin of 11.90% (TTM), a Debt-to-Equity ratio of 0.22x, a Price-to-Sales (P/S) ratio of 126.15x (TTM), a Price-to-Book (P/B) ratio of 1.40x (TTM), at a market cap of $6.82M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -25.00%
Gross Profit Margin TTM: 11.90%
Debt To Equity: 0.22x
P/S TTM: 126.15x
P/B TTM: 1.40x
Market Cap: $6.82M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Silo Pharma, Inc. in?

Silo Pharma, Inc. (SILO) operates in the Pharmaceutical Preparations industry.

What is SILO's market cap?

Silo Pharma, Inc. (SILO) has a market capitalization of $6.82M as of 2026-06-30.

What exchange does SILO trade on?

Silo Pharma, Inc. (SILO) trades on the Nasdaq.

Where is Silo Pharma, Inc. incorporated?

Silo Pharma, Inc. is incorporated in NV.

Silo Pharma, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Silo Pharma, Inc. (SILO) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Silo Pharma, Inc. (SILO) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.